As of October 30, 2025, the average one-year price target for Altimmune is $18.81/share. The forecasts range from a low of $1.01 to a high of $29.40. The average price target represents an increase of ...
Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform recommendation. As of February 19, 2025, the average one-year price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results